Day: October 13, 2021

An article Assessing the predictive response of a simple and sensitive blood-based biomarker between estrogen-negative solid tumors WOS:000613505100025 published article about EPITHELIAL OVARIAN CARCINOMAS; NITRIC-OXIDE SYNTHASE; HYDROXY-L-ARGININE; PROGNOSTIC VALUE; CANCER; EXPRESSION; RECEPTOR; MICROENVIRONMENT; THERAPIES; SURVIVAL in [Mohan, Srinidi; Patel, Seema; Barlow, David; Rojas, Augusto Cardenas] Univ New England, Coll Pharm, Dept Pharmaceut Sci, Portland, ME USA in 2020.0, Cited 28.0. Safety of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. The Name is 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Through research, I have a further understanding and discovery of 65-22-5

Purpose: We investigated Nw-hydroxy L-Arginine (NOHA) predictive response in serous ovarian carcinoma based on estrogen-hormone receptor expression status; and assessed the distinctive NOHA response between estrogen-receptor-negative (ER-) tumor subtypes of ovarian and breast cancer. Materials/methods: Three-dimensional (3D) spheroids models of ER- and estrogen-receptor-positive (ER+) from breast and ovarian tumor, cultured for 9 weeks, were assayed for cellular levels of inducible nitric oxide synthase (NOS2), nitric oxide (as total nitrite) and L-Arginine, and compared to NOHA in culture medium. Statistical difference was set at p < 0.01. Results: Nine-week in vitro studies showed a progressive NOHA reduction in culture medium by at least 0.4-0.8 fold, and 0.65-0.92 fold only in the ER-breast tumor and ER-ovarian tumor 3D spheroids, respectively; with increases in cellular NOS2 and nitric-oxide levels, by at least 1.0-2.45 fold in both ER-tumor subtype 3D spheroids (p < 0.01; n = 6). Within ER-subtypes, medium NOHA decreased by >= 38.9% in ovarian cancer over breast cancer 3D-spheroids, with cellular increases in NOS2 (by >= 17.4%), and nitric oxide (by >= 18.8%). Cellular L-Arginine to medium NOHA ratio was higher, and by at least 6.5-22.5 fold in ER-breast tumor 3D-spheroids, and at least 10-70 fold in ER-ovarian tumor 3D spheroids, than in ER+ and control conditions; and was >= 48% higher in ER-ovarian cancer than in ER-breast cancer 3D-spheroids. Conclusions: The present study shows NOHA as a sensitive and selective indicator differentiating and distinguishing ER-subtypes based on the tumor grade.

About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Mohan, S; Patel, S; Barlow, D; Rojas, AC or concate me.. Safety of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Recommanded Product: 91-02-1. Recently I am researching about ASYMMETRIC TRANSFER HYDROGENATION; LIGAND; EXTRACTION; SEPARATION; BEARING; ENANTIOSELECTIVITY; PALLADIUM; ACTINIDES, Saw an article supported by the . Published in PERGAMON-ELSEVIER SCIENCE LTD in OXFORD ,Authors: Wang, LD; Liu, TT. The CAS is 91-02-1. Through research, I have a further understanding and discovery of Phenyl(pyridin-2-yl)methanone

The transfer hydrogenation of ketones catalyzed by transition metal complexes has attracted much attention. A series of ruthenium(11) complexes bearing 2,6-bis(5,6-dialkyl-1,2,4-triazin-3-yl)pyridine ligands (R-BTPs) were synthesized and characterized by NMR analysis and X-ray diffraction. These ruthenium (II) complexes were applied in the transfer hydrogenation of ketones. Their different catalytic activity were attributed to the alkyl arms on the 2,6-bis(5,6-dialkyl-1,2,4-triazin-3-yl)pyridine. As the length of the alkyl arms rising, the catalytic activities of the complex catalysts decreased. By means of 0.4 mol % catalyst RuCl2(PPh3)(3-methylbutyl-BTP) in refluxing 2-propanol, a variety of ketones were reduced to their corresponding alcohols with >95% conversion over a period of 3 h. (C) 2019 Elsevier Science. All rights reserved. (C) 2019 Elsevier Ltd. All rights reserved.

About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Wang, LD; Liu, TT or concate me.. Recommanded Product: 91-02-1

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

An article Recognition of Thiols in Living Cells and Zebrafish Using an Imidazo[1,5-alpha]pyridine-Derivative Indicator WOS:000488830500120 published article about LARGE STOKES SHIFT; FLUORESCENT-PROBE; SELECTIVE DETECTION; CYSTEINE; GLUTATHIONE; SENSOR; HOMOCYSTEINE; ROLES in [Chen, Song; Hou, Peng; Sun, Jingwen; Wang, Haijun; Liu, Lei] Qiqihar Med Univ, Coll Pharm, Qiqihar 161006, Peoples R China in 2019.0, Cited 35.0. Safety of Phenyl(pyridin-2-yl)methanone. The Name is Phenyl(pyridin-2-yl)methanone. Through research, I have a further understanding and discovery of 91-02-1

A new cyan fluorescent probe, MIPY-DNBS, using an imidazo[1,5-alpha]pyridine derivative as the fluorophore and 2,4-dinitrobenzensufonate as the recognition site for the selective detection of thiols (Cys, GSH, and Hcy), was designed and synthesized. Probe MIPY-DNBS exhibited a 172 nm Stokes shift, a fast response time (400 s), low cytotoxicity, low detection limits (12.7 nM for Cys), and excellent selectively in the detection of thiols. In addition, MIPY-DNBS was successfully applied to imaging thiols in living MCF-7 cells and zebrafish.

Safety of Phenyl(pyridin-2-yl)methanone. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Chen, S; Hou, P; Sun, JW; Wang, HJ; Liu, L or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

SDS of cas: 614-18-6. I found the field of Chemistry very interesting. Saw the article Azine Activation via Silylium Catalysis published in 2021, Reprint Addresses List, B (corresponding author), Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany.. The CAS is 614-18-6. Through research, I have a further understanding and discovery of Ethyl nicotinate.

Practical, efficient, and general methods for the diversification of N-heterocycles have been a recurrent goal in chemical synthesis due to the ubiquitous influence of these motifs within bioactive frameworks. Here, we describe a direct, catalytic, and selective functionalization of azines via silylium activation. Our catalyst design enables mild conditions and a remarkable functional group tolerance in a one-pot setup.

About Ethyl nicotinate, If you have any questions, you can contact Obradors, C; List, B or concate me.. SDS of cas: 614-18-6

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Recently I am researching about NATURAL-PRODUCTS; MITOCHONDRIAL; DESIGN, Saw an article supported by the Ministry of Education and Science of the Russian FederationMinistry of Education and Science, Russian Federation [4.5821.2017/8.9]. Recommanded Product: 65-22-5. Published in ELSEVIER in AMSTERDAM ,Authors: Morkovnik, AS; Zubenko, AA; Divaeva, LN; Kartsev, VG; Borodkin, GS; Klimenko, AI. The CAS is 65-22-5. Through research, I have a further understanding and discovery of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride

A simple method for pyridoxal structural modification via furan ring closure was developed resulting in 2-acyl- and 2-heteroarylfuro[2,3-c]pyridines. The reaction products can be proposed as pyridoxal mimetics to inhibit pyridoxal 5′-phosphate-dependent enzymes.

Recommanded Product: 65-22-5. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Morkovnik, AS; Zubenko, AA; Divaeva, LN; Kartsev, VG; Borodkin, GS; Klimenko, AI or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Authors Imamura, F; Fretts, AM; Marklund, M; Ardisson Korat, AV; Yang, WS; Lankinen, M; Qureshi, W; Helmer, C; Chen, TA; Virtanen, JK; Wong, K; Bassett, JK; Murphy, R; Tintle, N; Yu, CI; Brouwer, IA; Chien, KL; Chen, Yy; Wood, AC; del Gobbo, LC; Djousse, L; Geleijnse, JM; Giles, GG; de Goede, J; Gudnason, V; Harris, WS; Hodge, A; Hu, F; Koulman, A; Laakso, M; Lind, L; Lin, HJ; McKnight, B; Rajaobelina, K; Riserus, U; Robinson, JG; Samieri, C; Senn, M; Siscovick, DS; Soedamah-Muthu, SS; Sotoodehnia, N; Sun, Q; Tsai, MY; Tuomainen, TP; Uusitupa, M; Wagenknecht, LE; Wareham, NJ; Wu, JHY; Micha, R; Lemaitre, RN; Mozaffarian, D; Forouhi, NG in PUBLIC LIBRARY SCIENCE published article about CORONARY-HEART-DISEASE; BETA-CELL TURNOVER; ADIPOSE-TISSUE; COFFEE CONSUMPTION; PLASMA; RISK; ASSOCIATION; BIOMARKERS; CANCER; PHOSPHOLIPIDS in [Imamura, Fumiaki; Koulman, Albert; Wareham, Nick J.; Forouhi, Nita G.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Fretts, Amanda M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Marklund, Matti; Riserus, Ulf] Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Nutr & Metab, Uppsala, Sweden; [Marklund, Matti; Wu, Jason H. Y.] Univ New South Wales, George Inst Global Hlth, Fac Med, Sydney, NSW, Australia; [Marklund, Matti; Micha, Renata; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Ardisson Korat, Andres V.; Hu, Frank] Harvard TH Chan Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA USA; [Ardisson Korat, Andres V.; Hu, Frank; Sun, Qi] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Ardisson Korat, Andres V.; Djousse, Luc; Hu, Frank; Sun, Qi] Harvard Med Sch, Boston, MA 02115 USA; [Yang, Wei-Sin; Chien, Kuo-Liong; Chen, Yun-yu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Lankinen, Maria; Virtanen, Jyrki K.; Tuomainen, Tomi-Pekka; Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Qureshi, Waqas] Wake Forest Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, Winston Salem, NC 27101 USA; [Helmer, Catherine; Rajaobelina, Kalina; Samieri, Cecilia] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, UMR 1219, Bordeaux, France; [Chen, Tzu-An; Wood, Alexis C.; Senn, Mackenzie] USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Baylor Coll Med, Houston, TX USA; [Wong, Kerry; Bassett, Julie K.; Giles, Graham G.; Hodge, Allison] Canc Council Victoria, Canc Epidemiol Div, Melbourne, Vic, Australia; [Murphy, Rachel] Univ British Columbia, Sch Populat Publ & Hlth, Ctr Excellence Canc Prevent, Fac Med, Vancouver, BC, Canada; [Tintle, Nathan] Dordt Univ, Dept Math & Stat, Sioux Ctr, IA USA; [Yu, Chaoyu Ian; McKnight, Barbara] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Brouwer, Ingeborg A.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Hlth Sci, Fac Sci, Amsterdam, Netherlands; [Chien, Kuo-Liong; Chen, Yun-yu] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [del Gobbo, Liana C.] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Djousse, Luc] Brigham & Womens Hosp, Dept Med, Div Aging, 75 Francis St, Boston, MA 02115 USA; [Geleijnse, Johanna M.; de Goede, Janette; Soedamah-Muthu, Sabita S.] Wageningen Univ, Div Human Nutr & Hlth, Wageningen, Netherlands; [Giles, Graham G.; Hodge, Allison] Univ Melbourne, Ctr Epidemiol & Biostat, Parkville, Vic, Australia; [Giles, Graham G.] Monash Univ, Sch Clin Sci Monash Hlth, Precis Med, Clayton, Vic, Australia; [Gudnason, Vilmundur] Iceland Heart Assoc Res Inst, Kopavogur, Iceland; [Harris, William S.] Univ South Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD USA; [Harris, William S.] OmegaQuant Analyt, Sioux Falls, SD USA; [Koulman, Albert] Univ Cambridge, Natl Inst Hlth Res, Addenbrookes Hosp, Biomed Res Ctr,Core Nutr Biomarker Lab, Cambridge, England; [Koulman, Albert] Univ Cambridge, Natl Inst Hlth Res, Addenbrookes Hosp, Biomed Res Ctr,Core Metabol & Lipid Lab, Cambridge, England; [Koulman, Albert] MRC, Elsie Widdowson Lab, Cambridge, England; [Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, Dept Med, Kuopio, Finland; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lin, Hung-Ju] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Robinson, Jennifer G.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Prevent Intervent Ctr, Iowa City, IA USA; [Siscovick, David S.] New York Acad Med, New York, NY USA; [Soedamah-Muthu, Sabita S.] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol & Somat Disorders, Tilburg, Netherlands; [Soedamah-Muthu, Sabita S.] Univ Reading, Inst Food Nutr & Hlth, Reading, Berks, England; [Sotoodehnia, Nona; Lemaitre, Rozenn N.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Wagenknecht, Lynne E.] Wake Forest Sch Med, Publ Hlth Sci, Winston Salem, NC 27101 USA in 2020.0, Cited 47.0. Recommanded Product: 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. The Name is 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Through research, I have a further understanding and discovery of 65-22-5

Background De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D). Methods and findings Seventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970-1973 to 2006-2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3-75.5 years; % women = 20.4%62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 16:0, 16:1n7, 18:0, and 18:1n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-varianceweighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41-1.66; p< 0.001) for 16:0, 1.40 (1.33-1.48; p< 0.001) for 16:1n-7, 1.14 (1.05-1.22; p = 0.001) for 18:0, and 1.16 (1.07-1.25; p< 0.001) for 18:1n9. Heterogeneity was seen across cohorts (I-2 = 51.1%-73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 16:0 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 16:0, 16:1n7, and 18:0 but were attenuated for 18:1n9 (RR = 1.03, 95% confidence interval (CI) = 0.94-1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors. Conclusions Concentrations of fatty acids in the DNL were positively associated with T2D incidence. Our findings support further work to investigate a possible role of DNL and individual fatty acids in the development of T2D. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Imamura, F; Fretts, AM; Marklund, M; Ardisson Korat, AV; Yang, WS; Lankinen, M; Qureshi, W; Helmer, C; Chen, TA; Virtanen, JK; Wong, K; Bassett, JK; Murphy, R; Tintle, N; Yu, CI; Brouwer, IA; Chien, KL; Chen, Yy; Wood, AC; del Gobbo, LC; Djousse, L; Geleijnse, JM; Giles, GG; de Goede, J; Gudnason, V; Harris, WS; Hodge, A; Hu, F; Koulman, A; Laakso, M; Lind, L; Lin, HJ; McKnight, B; Rajaobelina, K; Riserus, U; Robinson, JG; Samieri, C; Senn, M; Siscovick, DS; Soedamah-Muthu, SS; Sotoodehnia, N; Sun, Q; Tsai, MY; Tuomainen, TP; Uusitupa, M; Wagenknecht, LE; Wareham, NJ; Wu, JHY; Micha, R; Lemaitre, RN; Mozaffarian, D; Forouhi, NG or concate me.. Recommanded Product: 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Recently I am researching about PHOTOREDOX-CATALYSIS; FUNCTIONALIZATION; ALPHA; AMIDOALKYLATION; ETHERS, Saw an article supported by the National University of SingaporeNational University of Singapore; Ministry of Education of SingaporeMinistry of Education, Singapore [MOE2017-T2-2-081]; GSK-EDB [R-143-000-687-592]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [21702142, 21871205]. Name: Phenyl(pyridin-2-yl)methanone. Published in AMER CHEMICAL SOC in WASHINGTON ,Authors: Xu, JH; Wu, WB; Wu, J. The CAS is 91-02-1. Through research, I have a further understanding and discovery of Phenyl(pyridin-2-yl)methanone

Ortho-alkylated and ortho-acylated pyridines have been conveniently synthesized from pyridine N-oxides and alkynes under visible-light-mediation in a metal-free manner. The alkynes served as both alkylating and acylating agents via switching between anaerobic and aerobic conditions. The overall strategy accommodates a broad scope of substituted pyridine N-oxides and alkynes, with excellent regioselectivity in a number of cases.

About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Xu, JH; Wu, WB; Wu, J or concate me.. Name: Phenyl(pyridin-2-yl)methanone

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Recently I am researching about TRANSITION-METAL-COMPLEXES; X-RAY-STRUCTURE; PYRIDOXAL THIOSEMICARBAZONE; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; SPECTRAL CHARACTERIZATION; CATALYTIC APPLICATION; REDOX PROPERTIES; FREE-RADICALS, Saw an article supported by the . Recommanded Product: 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Published in ELSEVIER SCIENCE SA in LAUSANNE ,Authors: Bal-Demirci, T; Guveli, S; Yesilyurt, S; Ozdemir, N; Ulkuseven, B. The CAS is 65-22-5. Through research, I have a further understanding and discovery of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride

Mixed ligand nickel(II) and ruthenium(II) complexes were synthesized from pyridoxal-N-allyl-thiosemicarbazone hydrochloride and triphenylphosphine. The structures of the complexes have been characterized by elemental analysis, IR, H-1 and P-31 NMR, conductivity, magnetic moment measurements and single-crystal X-ray diffraction technique. Based on X-ray crystallographic studies, a square-planar structure has been proposed for the Ni(II) complex, in which the thiosemicarbazone ligand acts as dianionic tridentate ONS ligand. In the case of the Ru(II) complex, the thiosemicarbazone is coordinated to metal atom as a monoanionic bidentate NS donor ligand in an octahedral geometry. Antioxidant activities of the ligand and its metal complexes were calculated as their trolox equivalent antioxidant capacities (TEAC) by CUPRAC method and DPPH assay. Both the ligand and its metal complexes were found to be antioxidant and are much more antioxidant at least 2.1 times than trolox, even, ligand is 3.5 times greater than that of trolox according to CUPRAC. A linear correlation (correlation coefficient R-2 = 0.9997) appeared between the obtained TEAC values by the two antioxidant assays.

Recommanded Product: 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Bal-Demirci, T; Guveli, S; Yesilyurt, S; Ozdemir, N; Ulkuseven, B or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Recently I am researching about X-RAY-STRUCTURE; METAL-COMPLEXES; BIOLOGICAL EVALUATION; CRYSTAL-STRUCTURE; DNA-BINDING; METHYLDITHIOCARBAZATE SMDTC; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; CIRCULAR-DICHROISM; ZN(II) COMPLEXES, Saw an article supported by the Fundacao para a Ciencia e Tecnologia (FCT)Portuguese Foundation for Science and TechnologyEuropean Commission [UIDB/00100/2020, UIDP/00100/2020, PTDC/QUI-QAN/32242/2017, UID/Multi/00709/2019, UIDB/50006/2020, UIDB/04378/2020, SAICTPAC/0019/2015, PD/BD/128320/2017]; Programa Operacional Regional de Lisboa [LISBOA-01-0145-FEDER-007317]; FEDER fundsEuropean Commission [POCI-01-0145-FEDER-007491]. Published in ELSEVIER SCIENCE INC in NEW YORK ,Authors: Ramilo-Gomes, F; Addis, Y; Tekamo, I; Cavaco, I; Campos, DL; Pavan, FR; Gomes, CSB; Brito, V; Santos, AO; Domingues, F; Luis, A; Marques, MM; Pessoa, JC; Ferreira, S; Silvestre, S; Correia, I. The CAS is 65-22-5. Through research, I have a further understanding and discovery of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. SDS of cas: 65-22-5

Schiff bases (SB) obtained from S-methyl dithiocarbazate and aromatic aldehydes: salicylaldehyde (H2L1), ovanillin (H2L2), pyridoxal (H2L3) and 2,6-diformyl-4-methylphenol (H3L4), and their corresponding Zn(II)complexes (1-4), are synthesized. All compounds are characterized by elemental analyses, infrared, UV-Vis, nuclear magnetic resonance spectroscopy and mass spectrometry. The structures of H2L2 and [Zn-2(L-1)(2)(H2O) (DMF)] (1a) (DMF = dimethylformamide) are solved by single crystal X-ray diffraction. The SB coordinates the metal center through the Ophenolate, Nimine and Sthiolate atoms. The radical scavenging activity is tested using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, with all ligand precursors showing IC50 values similar to 40 mu M. Cytotoxicity studies with several tumor cell lines (PC-3, MCF-7 and Caco-2) as well as a non-tumoral cell line (NHDF) are reported. Interestingly, 1 has relevant and selective antiproliferative effect against Caco-2 cells (IC50 = 9.1 mu M). Their antimicrobial activity is evaluated in five bacterial strains (Klebsiella pneumoniae, Acinetobacter baumannii, Listeria monocytogenes, Pseudomonas aeruginosa and Staphylococcus aureus) and two yeast strains (Candida albicans and Candida tropicalis) with some compounds showing bacteriostatic and fungicidal activity. The minimal inhibitory concentration (MIC90) of HnL against Mycobacterium tuberculosis is also reported, with H2L2 and H3L4 showing very high activity (MIC90 < 0.6 mu g/mL). The ability of the compounds to bind bovine serum albumin (BSA) and DNA is evaluated for H3L4 and [Zn-2(L-4)(CH3COO)] (4), both showing high binding constants to BSA (ca. 106 M 1) and ability to bind DNA. Overall, the reported compounds show relevant antitumor and antimicrobial properties, our data indicating they may be promising compounds in several fields of medicinal chemistry. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Ramilo-Gomes, F; Addis, Y; Tekamo, I; Cavaco, I; Campos, DL; Pavan, FR; Gomes, CSB; Brito, V; Santos, AO; Domingues, F; Luis, A; Marques, MM; Pessoa, JC; Ferreira, S; Silvestre, S; Correia, I or concate me.. SDS of cas: 65-22-5

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Quality Control of Phenyl(pyridin-2-yl)methanone. I found the field of Chemistry very interesting. Saw the article Engineering an alcohol dehydrogenase with enhanced activity and stereoselectivity toward diaryl ketones: reduction of steric hindrance and change of the stereocontrol element published in 2020.0, Reprint Addresses Shao, L (corresponding author), Shanghai Univ Med & Hlth Sci, Microbial Pharmacol Lab, 279 Zhouzhu Highway,Pudong New Area, Shanghai 201318, Peoples R China.; Shao, L (corresponding author), Shanghai Inst Pharmaceut Ind, State Key Lab New Drug & Pharmaceut Proc, 285 Gebaini Rd, Shanghai 200040, Peoples R China.. The CAS is 91-02-1. Through research, I have a further understanding and discovery of Phenyl(pyridin-2-yl)methanone.

Steric hindrance in the binding pocket of an alcohol dehydrogenase (ADH) has a great impact on its activity and stereoselectivity simultaneously. Due to the subtle structural difference between two bulky phenyl substituents, the asymmetric synthesis of diaryl alcohols by bioreduction of diaryl ketones is often hindered by the low activity and stereoselectivity of ADHs. To engineer an ADH with practical properties and to investigate the molecular mechanism behind the asymmetric biocatalysis of diaryl ketones, we engineered an ADH from Lactobacillus kefiri (LkADH) to asymmetrically catalyse the reduction of 4-chlorodiphenylketones (CPPK), which are not catalysed by the wild type (WT) enzyme. Mutants seq1-seq5 with gradually increased activity and stereoselectivity were obtained through iterative shrinking mutagenesis. The final mutant seq5 (Y190P/I144V/L199V/E145C/M206F) demonstrated the highest activity and excellent stereoselectivity of >99% ee. Molecular simulation analyses revealed that mutations may enhance the activity by eliminating steric hindrance, inducing a more open binding loop and constructing more noncovalent interactions. The pro-R pose of CPPK with a halogen bond formed a pre-reaction conformation more easily than the pro-S pose, resulting in the high ee of (R)-CPPO in seq5. Moreover, different halogen bonds formed due to the different positions of chlorine substituents, resulting in opposite substrate binding orientation and stereoselectivity. Therefore, the stereoselectivity of seq5 was inverted toward ortho- rather than para-chlorine substituted ketones. These results indicate that the stereocontrol element of LkADH was changed to recognise diaryl ketones after steric hindrance was eliminated. This study provides novel insights into the role of steric hindrance and noncovalent bonds in the determination of the activity and stereoselectivity of enzymes, and presents an approach producing key intermediates of chiral drugs with practical potential.

About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Wu, K; Yang, ZJ; Meng, XG; Chen, R; Huang, JK; Shao, L or concate me.. Quality Control of Phenyl(pyridin-2-yl)methanone

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem